Both in Pharmaceuticals
Teva Pharmaceutical Industries Limited vs Royalty Pharma
Over the past year TEVA returned +103.6% and RPRX returned +77.5%; their daily moves had a correlation of 0.41.
TEVA +103.6% RPRX +77.5%Growth of $1, one year, split-adjusted
| Metric | TEVA | RPRX |
|---|---|---|
| Price | $41.91 | $66.40 |
| Market cap | $48.88B | $29.57B |
| Today | +2.97% | −0.18% |
| 1 month | +5.7% | +17.2% |
| 6 months | +16.9% | +31.6% |
| Year to date | +34.3% | +71.8% |
| 1 year | +104.6% | +76.9% |
| Revenue growth (YoY) | −0.8% | +16.5% |
| Gross margin | 52.0% | 100.0% |
| Net margin | −13.9% | 2.7% |
| P/E (TTM) | 69.1× | 36.3× |
| Price / sales | 2.8× | 11.7× |
| Net cash | -$12.94B | -$8.23B |
| Dividend yield | — | 1.42% |
| Volatility (60d) | 28.5% | 24.6% |
| Short % of float | 2.4% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).